Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel J Waters

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Drug Metabolism|October 27, 2010
The role of metabonomics at the interface between drug metabolism and safety assessmentNigel J Waters
British Journal of Clinical Pharmacology|December 3, 2014
Evaluation of drug-drug interactions for oncology therapies: in vitro-in vivo extrapolation model-based risk assessmentNigel J Waters
European Journal of Drug Metabolism and Pharmacokinetics|February 24, 2017
Preclinical Pharmacokinetics and Pharmacodynamics of Pinometostat (EPZ-5676), a First-in-Class, Small Molecule S-Adenosyl Methionine Competitive Inhibitor of DOT1LNigel J Waters
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 9, 2010
Use of the Øie-Tozer model in understanding mechanisms and determinants of drug distributionNigel J Waters, Franco Lombardo
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 2016
Physiologically Based Pharmacokinetic Modeling in Pediatric Oncology Drug DevelopmentNathalie Rioux, Nigel J Waters
Pharmaceutical Research|December 30, 2018
Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid GlycoproteinSherri A Smith, Nigel J Waters
Journal of Chemical Information and Modeling|June 22, 2012
In silico prediction of total human plasma clearanceGiuliano Berellini, Nigel J Waters, Franco Lombardo
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 2017
Implications for Metabolite Quantification by Mass Spectrometry in the Absence of Authentic StandardsPanos Hatsis, Nigel J Waters, Upendra A Argikar
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compoundsR Scott Obach, Franco Lombardo, Nigel J Waters
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Consideration of the unbound drug concentration in enzyme kineticsNigel J Waters, R Scott Obach, Li Di
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Drug Metabolism|October 27, 2010
The role of metabonomics at the interface between drug metabolism and safety assessmentNigel J Waters
British Journal of Clinical Pharmacology|December 3, 2014
Evaluation of drug-drug interactions for oncology therapies: in vitro-in vivo extrapolation model-based risk assessmentNigel J Waters
European Journal of Drug Metabolism and Pharmacokinetics|February 24, 2017
Preclinical Pharmacokinetics and Pharmacodynamics of Pinometostat (EPZ-5676), a First-in-Class, Small Molecule S-Adenosyl Methionine Competitive Inhibitor of DOT1LNigel J Waters
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 9, 2010
Use of the Øie-Tozer model in understanding mechanisms and determinants of drug distributionNigel J Waters, Franco Lombardo
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 2016
Physiologically Based Pharmacokinetic Modeling in Pediatric Oncology Drug DevelopmentNathalie Rioux, Nigel J Waters
Pharmaceutical Research|December 30, 2018
Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid GlycoproteinSherri A Smith, Nigel J Waters
Journal of Chemical Information and Modeling|June 22, 2012
In silico prediction of total human plasma clearanceGiuliano Berellini, Nigel J Waters, Franco Lombardo
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 2017
Implications for Metabolite Quantification by Mass Spectrometry in the Absence of Authentic StandardsPanos Hatsis, Nigel J Waters, Upendra A Argikar
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compoundsR Scott Obach, Franco Lombardo, Nigel J Waters
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Consideration of the unbound drug concentration in enzyme kineticsNigel J Waters, R Scott Obach, Li Di
Pageof 5